Cadence Neuroscience is developing a neuromodulation system that detects specific brain signals and delivers targeted electrical stimulation to modify neural circuit activity. This technology aims to provide personalized treatment options for epilepsy and other neurological disorders that are inadequately managed by existing therapies.
Funding
$26M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ALFounders
Product
Problem
Many neurological disorders, such as epilepsy, are not adequately managed by existing therapies. Current treatment options often fail to provide sufficient relief, leaving patients with unmet needs.
Solution
Cadence Neuroscience is developing a novel neuromodulation system designed to detect specific brain signals and deliver targeted electrical stimulation. This approach aims to modify neural circuit activity in a personalized manner, offering a potential solution for neurological diseases inadequately addressed by current treatments. The technology, based on research from Mayo Clinic, is currently undergoing clinical trials to evaluate its efficacy. The system's ability to detect and respond to specific brain signals allows for a more tailored and potentially more effective therapeutic intervention.
Target Audience
The primary target audience includes individuals with epilepsy and other neurological disorders who are not adequately managed by existing therapies.
Features
- Neuromodulation system capable of detecting specific brain signals.
- Targeted electrical stimulation to modify neural circuit activity.
- Personalized approach to treatment based on individual brain signals.